Free Trial

Belite Bio (BLTE) Stock Forecast & Price Target

$49.98
+1.18 (+2.42%)
(As of 06/12/2024 ET)

Belite Bio - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Buy
Based on 7 Analyst Ratings

Consensus Price Target

$44.83
-10.29% Downside
High Forecast$60.00
Average Forecast$44.83
Low Forecast$25.00
TypeCurrent Forecast
6/14/23 to 6/13/24
1 Month Ago
5/15/23 to 5/14/24
3 Months Ago
3/16/23 to 3/15/24
1 Year Ago
6/14/22 to 6/14/23
Consensus Rating
Buy
Buy
Buy
Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
7 Buy rating(s)
7 Buy rating(s)
7 Buy rating(s)
2 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$44.83$44.83$44.83$56.00
Forecasted Upside-10.29% Downside47.86% Upside49.65% Upside116.87% Upside
Get Belite Bio Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for BLTE and its competitors with MarketBeat's FREE daily newsletter.

BLTE Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

BLTE Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Belite Bio Stock vs. The Competition

TypeBelite BioMedical CompaniesS&P 500
Consensus Rating Score
3.00
2.70
2.50
Consensus RatingBuyModerate BuyHold
Predicted Upside-10.29% Downside862.28% Upside10.89% Upside
News Sentiment RatingPositive News
Positive News
Positive News

Recent Analyst Forecasts and Stock Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
6/13/2024HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$59.00 ➝ $59.00+18.06%
5/16/2024Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$57.00+36.36%
5/15/2024Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOverweight
12/14/2023Maxim Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$60.00+35.76%
7/26/2023Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
M. Goodman
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform
7/26/2023SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
M. Goodman
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform$25.00+39.66%
7/26/2023SVB Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$25.00+39.66%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 09:01 AM ET.

BLTE Frequently Asked Questions

What is Belite Bio's stock forecast and purchase recommendation?

According to the research reports of 7 Wall Street equities research analysts, the average twelve-month stock price forecast for Belite Bio is $44.83, with a high forecast of $60.00 and a low forecast of $25.00. The consensus rating for Belite Bio stock is Buy based on the current 7 buy ratings for BLTE. Learn more on BLTE's analyst rating history.

Do Wall Street analysts like Belite Bio more than its competitors?

Analysts like Belite Bio more than other "medical" companies. The consensus rating for Belite Bio is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how BLTE compares to other companies.

Does Belite Bio's stock price have much upside?

According to analysts, Belite Bio's stock has a predicted upside of 35.45% based on their 12-month stock forecasts.

What analysts cover Belite Bio?

Belite Bio has been rated by research analysts at Benchmark, Cantor Fitzgerald, and HC Wainwright in the past 90 days.


Stock Forecasts and Research Tools

This page (NASDAQ:BLTE) was last updated on 6/13/2024 by MarketBeat.com Staff

From Our Partners